canin
parvoviru
cpv
prevent
caus
morbid
young
dog
caus
hemorrhag
enter
leukopenia
sepsi
cardiovascular
compromis
virul
cpv
strain
undergon
genet
alter
past
four
decad
subsequ
develop
antigen
differ
subtyp
signific
differ
diseas
sever
outcom
compar
versu
surviv
follow
cpv
infect
depend
upon
adequ
product
antibodi
follow
recoveri
lymphoid
intestin
crypt
cell
mortal
rate
untreat
case
cpv
approach
hospit
aggress
support
care
reduc
mortal
rate
dog
present
sepsi
septic
shock
earli
resuscit
effort
critic
surviv
immedi
medic
intervent
includ
cardiovascular
stabil
use
intraven
fluid
iv
resuscit
correct
lifethreaten
electrolyt
glucos
derang
prompt
antimicrobi
protect
bacteri
transloc
cardiovascular
stabil
achiev
iv
access
fluid
resuscit
fluid
therapi
effect
target
specif
resuscit
endpoint
concept
refer
earli
goaldirect
therapi
smaller
aliquot
mlkg
iv
minut
isoton
crystalloid
titrat
normal
cardiovascular
paramet
isoton
crystalloid
rapidli
dispers
intravascular
interstiti
space
may
necessit
use
fluid
type
optim
intravascular
volum
cpv
dog
includ
addit
colloid
support
fluid
therapi
plan
one
studi
dog
hemorrhag
diarrhea
identifi
clear
benefit
inclus
synthet
colloid
fluid
therapi
inform
regard
advers
effect
hydroxyethylstarch
eg
develop
coagulopathi
acut
kidney
injuri
increas
awar
regard
use
veterinari
set
author
experi
synthet
colloid
may
use
cpv
dog
small
amount
short
period
time
without
clear
advers
effect
option
colloid
support
includ
natur
sourc
albumin
either
fresh
frozen
plasma
caninespecif
albumin
csa
fresh
frozen
plasma
found
improv
select
cardiovascular
paramet
eg
shock
index
blood
lactat
concen
tration
cpv
dog
compar
isoton
crystalloid
fluid
bolu
practition
aim
use
fluid
combin
fluid
manner
meet
target
goal
establish
accept
perfus
paramet
individu
anim
broadspectrum
antimicrobi
therapi
use
bactericid
parenter
product
indic
neutropen
cpv
dog
gramneg
anaerob
bacteri
flora
intestin
tract
caus
secondari
bacteremia
system
inflamm
septic
shock
tradit
antimicrobi
recommend
includ
extend
spectrum
penicillin
second
gener
cephalosporin
penicillin
pair
fluoro
quinolon
cefovecin
demonstr
accept
antimicrobi
activ
escherichia
coli
clostridium
speci
activ
bacteria
enteropathogen
evalu
cpv
dog
use
cefovecin
limit
select
case
tradit
antimicrobi
use
eg
outpati
therapi
coinfect
nonbacteri
pathogen
canin
circoviru
giardia
crypto
sporidium
coronaviru
complic
treatment
cpv
organ
highlight
possibl
interact
coinfect
morbid
mortal
observ
cpv
presenc
familiar
intestin
wwwadvancesinsmallanimalcom
volum
issu
novemb
n
l
l
n
l
e
c
n
e
n
u
r
g
e
r
enter
nutrit
provid
soon
cardiovascular
statu
stabl
vomit
control
enter
nutrit
may
provid
syring
feed
nasoesophag
nasogastr
tube
circumst
tube
feed
possibl
appetit
may
return
quickli
use
oral
recuper
fluid
fluid
aid
gastrointestin
tract
heal
nutrit
assist
dog
recoveri
phase
ill
ancillari
therapi
may
consid
treat
cpv
although
dog
posit
respond
support
care
nacetylcystein
nac
mgkg
iv
day
precursor
glutathion
potent
antioxid
recent
found
help
amelior
oxid
stress
cpv
dog
compar
support
treatment
alon
cpv
dog
treat
nac
also
experienc
rapid
return
leukocyt
count
first
day
hospit
although
larger
benefit
nac
eg
shorter
durat
hospit
yet
establish
hospit
intens
care
quickli
becom
resourceprohibit
necessit
altern
strategi
provid
medic
manag
critic
ill
cpv
dog
circumst
modifi
treatment
protocol
may
use
shelter
lowcost
set
studi
indic
outpati
care
viabl
option
commit
owner
will
provid
care
home
recheck
regularli
veterinarian
outpati
care
best
provid
puppi
initi
receiv
iv
fluid
resuscit
cardiovascularli
stabl
absorpt
subcutan
fluid
medic
optim
puppi
normovolem
normotherm
fluid
resuscit
lifethreaten
glucos
electrolyt
derang
also
address
puppi
transit
outpati
care
stabil
electrolyt
abnorm
may
persist
outpati
care
requir
oral
supplement
approxim
outpati
dog
requir
dextros
supplement
requir
potassium
supplement
routin
supplement
recommend
due
frequenc
electrolyt
abnorm
regular
veterinari
evalu
also
recommend
owner
may
recogn
clinic
decompens
may
warrant
aggress
intervent
euthanasia
individu
adjust
outpati
protocol
may
also
provid
visit
due
infecti
natur
cpv
bring
veterinari
staff
owner
vehicl
daili
assess
puppi
help
prevent
clinic
contamin
outcom
prognosi
cpv
variabl
depend
sever
factor
age
breed
vaccin
histori
concurr
ill
time
medic
intervent
level
medic
care
provid
may
play
role
overal
prognosi
rebound
variou
leukocyt
paramet
first
hour
hospit
associ
surviv
vaccin
remain
safest
costeffect
mean
prevent
cpv
infect
guidelin
publish
aaha
recommend
initi
cpv
vaccin
earli
week
age
provid
sequenti
dose
everi
week
minimum
age
week
dog
increas
risk
infect
aaha
recommend
addit
vaccin
week
age
